1. 1) Cockshott, A. Regulatory Toxicology and Pharmacology, 2008, 50, 170.
2. 2) Interagency Coordinating Committee on the Validation of Alternative Methods. ICCVAM Test Method Evaluation Report on the Murine Local Lymph Node Assay: BrdU-ELISA. A Nonradioactive Alternative Test Method to Assess the Allergic Contact Dermatitis Potential of Chemicals and Products. https://ntp.niehs.nih.gov/iccvam/docs/immunotox_docs/llna-elisa/tmer.pdf（accessed December 8, 2021）.
3. 3) Interagency Coordinating Committee on the Validation of Alternative Methods. ICCVAM Test Method Evaluation Report: Usefulness and Limitations of the Murine Local Lymph Node Assay for Potency Categorization of Chemicals Causing Allergic Contact Dermatitis in Humans. https://ntp.niehs.nih.gov/iccvam/docs/immunotox_docs/llna-pot/tmer.pdf（accessed on December 8, 2021）.
4. 4) Maeda, Y.; Takeyoshi, M. Regul. Toxicol. Pharmacol. 2019, 107, 104409.
5. 5) Kobayashi, T.; Maeda, Y.; Kondo, H.; Takeyoshi, M. J. Appl. Toxicol. 2020, 40, 1435.